The Latest
FIS Harvard 2019

FIS Harvard 2019 podcasts

The Fiduciary Investors Symposium at Harvard University brought together more than 85 asset owners from 20 countries to discuss globalisation, human capital, inequality, longevity, technology, medicine and ethics, and the role of institutional capital in creating real change in the world. We were joined by many distinguished speakers and have put together a podcast series of our favourite sessions.
FIS Harvard 2019

Healthcare’s multiple opportunities

William Haseltine had a long career at Harvard Medical School, educating a generation of doctors, and designing the strategy to develop the first treatment for HIV/AIDS. He addressed the Fiduciary Investors Symposium about important topics in medicine and health development.
FIS Harvard 2019

Threats to equity bond correlation

A full-blown trade war, and changes in monetary policy triggered by a loss of credibility in the Federal Reserve and other global policy institutions, could result in a return of the positive correlation between bonds and stocks, and investors need to be aware of the risk, warned Luis Viceira, George E. Bates Professor in the Finance Unit and Senior Associate Dean for Executive Education at Harvard Business School, at the Fiduciary Investors’ Symposium at Harvard University.
FIS Harvard 2019

Inequality risk equal to climate change

Rebecca Henderson, the John and Natty McArthur University Professor at Harvard University who co-teaches Reimagining Capitalism at HBS, says inequality is equal to climate risk in its potential impact. She told delegates at the Fiduciary Investors Symposium at Harvard University when a system no longer generates freedom and prosperity it must be changed. Change is possible because we have the resources and technology to do it. A first move is decent jobs for people at the “bottom”.
FIS Harvard 2019

We are going to live longer; prepare now

Understanding the economic implications of changing demographics is essential for investors, said Aubrey de Grey, a biomedical gerontologist speaking at the Fiduciary Investors' Symposium at Harvard University He said the technology exists today so that the ageing process can be combated and people will live much longer in the future than what they do today, so really “longevity is a side effect of health”. He urged investors to think about how people living longer will affect consumer behaviour and investee companies.
<1of2>